SELPLG Antibody (LS-B2507)

貨號 Cat. No.
LS-B2507
規格 Size
50 µg
品牌 Brand
LSBio

Description
















































































Antibody Catalog ID: LS-B2507
Antibody Validation: This antibody replaces catalog number LS-C35859. It has been validated for use in the following assays: IHC-P.
Antibody Target: SELPLG
Synonyms: SELPLG Antibody, CD162 Antibody, CLA Antibody, p-selectin glycoprotein ligand 1 Antibody, PSGL-1 Antibody, PSGL1 Antibody
Host: SELPLG antibody was produced in Mouse
Antigen Species: SELPLG antibody was raised against Human
Clonality: Monoclonal
Isotype: IgG1
Modifications: Biotin (Biotin)
Antigen Type: Purified protein
Immunogen: SELPLG antibody was raised against purified (With Antibiotics) human neutrophil PSGL-1
Antibody Specificity: Recognizes human CD162 molecule at 120kD within a region containing aa51-63.
Antigen Modification: aa51-63
Purification: Protein A Column
Presentation: FBS, 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride, 5% glycerol, 0.2% BSA, 0.04% sodium azide.
Recommended Storage: Short term: 4º C, Long term: add sterile glycerol (40-50%), aliquot to avoid repeated freezing and thawing, and store at -20º C.
Antibody Usage Summary: Immunohistochemistry: LS-B2507 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D2, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2507 was determined to be 5 ug/ml.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (5 µg/ml), Immunohistochemistry - Frozen (IHC-Fr), Western blot (WB), Flow Cytometry (Flo) (Optimal dilution to be determined by the researcher)
Size: 50 µg

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢